Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yunzhi Gantai Capsule is a pharmaceutical product developed and manufactured by Jiangsu Shenhua Pharmaceutical. It is a Traditional Chinese Medicine (TCM) formulation primarily composed of polysaccharides extracted from the fungus *Trametes versicolor* (also known as *Coriolus versicolor* or Yunzhi). The drug is approved in China for the treatment of chronic hepatitis, including chronic persistent hepatitis and chronic active hepatitis. It functions as an immunomodulator, enhancing cellular immune responses by stimulating T-lymphocytes and natural killer (NK) cells, while also providing hepatoprotective effects to improve liver function and alleviate symptoms such as fatigue and liver pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yunzhi gantai capsule.